oustanding value

biotechs are not flavour of the month but the last bull cycle ended in 2004, the average bull cycle is due 4 years after the last one ended which means the next biotech cycle is due to start in 2008/09 .
psd is outstanding value, low market cap, platform technology with hundreds of patents and numorous applications. currently has products in phase 11 and phase 111 trials. enough cash from asset sales due and licencing fees due to see it get through 2008/2009.